Covid-19: Public health agencies review whether vitamin D supplements could reduce risk
Ingrid Torjesen
Abstract
Covid-19: Public health agencies review whether vitamin D supplements could reduce risk As agencies announce they are examining whether vitamin D supplements could reduce the risk of covid-19, Ingrid Torjesen finds out what the existing evidence shows Ingrid Torjesen Public health agencies in England and Scotland are conducting urgent reviews into the potential for vitamin D to reduce the risk of covid-19.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Public health2019-20 coronavirus outbreakMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Vitamin D and neurologyEnvironmental healthBusinessRisk assessmentVirologyComputer scienceComputer securityNursingPathologyDiseaseInfectious disease (medical specialty)OutbreakEndocrinologyVitamin D Research StudiesVitamin C and Antioxidants ResearchHealthcare cost, quality, practices